The Regenerative Medicine Research is a research journal published by the EDP Sciences. The P-ISSN of this journal is .
Also, please check the following important details about regenerative medicine research: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
Journal Title: | Regenerative Medicine Research |
Publisher: | EDP Sciences |
P-ISSN: | |
Open Access: | |
Status: | Inactive |
Scopus Coverage: | 2014 |
The regenerative medicine research is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.
According to journal website, the publication fee of regenerative medicine research is around 900 EUR.
The regenerative medicine research has also Journal waiver policy (for developing countries, authors etc).
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the regenerative medicine research publishes research articles in 6 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to the scope of the journal, then visit the official website of regenerative medicine research and send your manuscript.